Dec 30, 202413:44GMT+7
Japanese shares edged lower on Monday, mirroring Wall Street's Friday slide as elevated treasury yields weighed on equity valuations, prompting caution ahead of the year-end.
The Nikkei 225 dipped 0.92%, closing down 369.35 points at 39,911.81.
US markets remain a focal point, with the S&P 500 up 25% and the Nasdaq 31% this year, straining valuations against treasury yields near eight-month highs at 4.631%.
Ten-year yields have risen 75 basis points this year despite the Federal Reserve cutting cash rates by 100 basis points.
Economic data offered mixed signals. Japan's manufacturing PMI inched up to 49.6 in December from 49 in November, S&P Global said Monday. Output and new orders contracted more slowly, though demand from China and the US stayed weak.
Input stocks fell sharply, while employment rebounded, rising for the ninth time in 10 months.
As part of corporate moves, JCR Pharmaceuticalsgained orphan drug designation for JR-441, a Sanfilippo syndrome treatment developed with its J-Brain Cargo technology.
Kudandemonstrated autonomous factory transport vehicles addressing labor shortages in collaboration with a Japanese manufacturer.
Meanwhile, Ateamdisclosed plans to acquire WCA, an ad agency specializing in education, automotive, and bridal services, to enhance its digital marketing offerings.
Sumber : MT Newswires
powered by: IPOTNEWS.COM
